Nature Chemical Biology is a monthly, peer-reviewed, scientific journal, which is published by Nature Publishing Group. It was first published in June 2005 (volume 1, issue 1). Terry L. Sheppard is a full-time professional editor with the title, "Chief Editor", and employed by Nature Chemical Biology. The impact factor for Nature Chemical Biology in 2010 is 15.808, according to the Journal Citation Reports. The publishing focus of Nature Chemical Biology is a forum for original research and commentary in Chemical-biology. Published topics encompass concepts and research methods in chemistry, biology, and related disciplines with the end result of controlling biological systems at the molecular level. Authors (contributors) are chemical biologists, also chemists involved in interdisciplinary research between chemistry and biology, along with biologists who produce research results in understanding and controlling biological processes at the molecular level. Interdisciplinary research in chemistry and biology is emphasized. The journal s main focus in this area is fundamental research which illuminates available chemical and biological tools, as well as mechanisms underpinning
The commonly used chemotherapy drug doxorubicin can damage heart muscle, in some cases leading to severe or lethal heart failure. A new study led by Albert Einstein College of Medicine researchers and involving zebrafish ...
Mar 04, 2020
0
107
Two recently approved leukemia drugs could be enlisted against treatment-resistant lung cancer, with a clinical trial expected to launch in Toronto and Zagreb, Croatia, later this year to evaluate one of them.
Feb 24, 2020
0
122
Researchers from the Ontario Institute for Cancer Research (OICR) and the Structural Genomics Consortium (SGC) at the MaRS Discovery District in Toronto have developed a new drug prototype called OICR-9429 and made it freely ...
Sep 03, 2015
0
132
In the natural course of events, multicellular organisms frequently need to eliminate cells. In humans, for example, superfluous tails, finger webbing, immune cells raised with wrongthink or neurons making inappropriate friends ...
Scientists on Monday said they had unlocked a pathway for producing opiates from genetically-engineered yeast but feared the discovery could one day be a bonanza for drug lords.
May 18, 2015
0
13
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. Scientists at The Scripps Research Institute (TSRI) ...
Dec 08, 2017
0
2477
Treating type 1 diabetes and some cases of type 2 diabetes has long required painful and frequent insulin injections or a mechanical insulin pump for insulin infusion. But researchers from the University of North Carolina ...
Oct 30, 2017
0
3163
Northwestern Medicine scientists have used an innovative gene editing technique to identify the genes that may lead to Parkinson's disease after exposure to paraquat, a commonly-used herbicide.
Oct 23, 2017
1
1453
Treatments for chronic inflammatory diseases are one step closer as University of Queensland researchers discover a way to stop inflammation in its tracks.
May 13, 2019
0
439
The cells of most patients' cancers are resistant to a class of drugs, called proteasome inhibitors, that should kill them. When studied in the lab, these drugs are highly effective, yet hundreds of clinical trials testing ...
May 28, 2019
0
185
